bioMérieux SA (0RUG)
LSE
74.55
-1.13 (-1.49%)
Closed
Aug 26, 2026
Day's Range
74.4576.70
52 wk Range
28.87123.10
Financial Statements - 0RUG - bioMérieux SA
Revenue
4.06B▲ 2.3%
Net Income
396.90M▼ 6.6%Net Margin 9.8%
EBITDA
1.03B▲ 8.8%
Free Cash Flow
453.10M▲ 40.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.06B | 3.97B | 3.67B | 3.58B | 3.37B | 3.11B |
| Cost of Goods | 1.76B | 1.76B | 1.61B | 1.58B | 1.37B | 1.36B |
| Gross Profit | 2.30B | 2.21B | 2.05B | 2B | 2B | 1.75B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 694.70M | 637.90M | 568.90M | 625.70M | 844M | 612.40M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 525.70M | 579.30M | 437.50M | 580.50M | 774.50M | 524.40M |
| Income Tax | 128.80M | 154.30M | 114.50M | 140.10M | 175.60M | 121.50M |
| Net Income | 396.90M | 425.10M | 322.80M | 440.50M | 598.20M | 402.70M |
| EPS Basic | - | 3.67 | 3.03 | 3.84 | 5.08 | 3.42 |
| EPS Diluted | - | 3.64 | 3.01 | 3.82 | 5.06 | 3.41 |
| Basic Shares Outstanding | - | 117.76M | 118.15M | 117.94M | 118.26M | 118.14M |
| Diluted Shares Outstanding | - | 117.76M | 118.15M | 117.94M | 118.26M | 118.14M |
| Ebit | 541.50M | 595.30M | 453.30M | 584.60M | 783.60M | 549.30M |
| Ebitda | 1.03B | 948.30M | 841.80M | 875.60M | 1.09B | 825.40M |
| Net Income Continuous Operations | 396.90M | 425.10M | 322.80M | 440.50M | 598.20M | 402.70M |
| Minority Interests | 600K | 7.10M | 34.80M | 11.80M | 2.90M | 1.70M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
